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ABSTRACT
Mycobacteriophage (phage) are abundant viruses that infect bacteria of the genus
Mycobacterium. Pathogenic species of Mycobacterium carry prophage that are
hypothesized to contribute to virulence. The term “prophage” describes a dormant phage
during lysogeny, which occurs when a phage genome integrates itself into the host
genome. Understanding the interactions between bacterial host and prophage may
improve our ability to treat disease caused by bacteria. Phage are highly diverse and are
sorted into clusters based on genome sequence similarity. To determine which phage
infect and form lysogens in mycobacterial fish pathogens, we applied viral dosages of
phage representative of clusters A–X to lawns of M. chelonae and M. marinum. The
ability for phage to infect these alternative hosts is cluster-dependent. Two phage, BPs
(cluster G) and Wildcat (cluster V), infected M. chelonae the most efficiently. BPs was
able to form lysogens in M. chelonae. The ability for BPs to form lysogens in M.
chelonae is not surprising since its genome encodes an integrase and a repressor, and BPs
is also able to form stable lysogens in its isolation host, M. smegmatis. However, despite
their highly conserved genomes, Wildcat and an additional cluster V phage, EniyanLRS,
display different lysogen phenotypes. Future work includes identifying genes in both
Wildcat and EniyanLRS that may play a role in lysogenic maintenance and performing
RNA sequencing analysis to determine how prophage affect bacterial gene expression.
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1.0 Introduction

Over the past century, mortality rates due to infectious disease have decreased
significantly thanks to public health education, awareness, and research efforts
(Armstrong, 1999). However, infectious diseases still account for 84% of health hazards
and are especially prevalent in underdeveloped areas of the world (Dye, 2014). Bacterial
pathogens contribute significantly to this public health concern, and all serious bacterial
pathogens carry prophage, which are bacteriophage genomes that are integrated into the
host chromosome (Brussow, 2004). In many species of bacteria, the prophage they carry
are functional and encode virulence factors that directly impact the overall pathogenicity
or fitness of the host bacterium. These species include E. coli 0157, Salmonella
typhimurium, and Clostridium difficile (Shaikh, N., 2003; Lopez, C., 2012; Hargreaves,
K., 2014). However, in some species of bacteria, such as Mycobacterium tuberculosis,
the function of the prophage is unknown (Cole, 1998).
Investigating how mycobacteriophage impact gene expression in pathogenic
mycobacteria may help us better understand host virulence. Mycobacteriophage (phage)
are viruses that infect bacteria of the genus Mycobacterium. They are extremely abundant
and diverse, and in order to understand this diversity, phage are classified into clusters
based on genome sequence similarity (Hatfull, 2008). There are currently 27 clusters, A–
Z, along with 6 singletons, phage that do not share at least 50% genome similarity with
other phage. Over 8,300 phage have been isolated, with over 99% being isolated using
the non-pathogenic host M. smegmatis (phagesdb.org). Phage typically use one of two
life cycles: lytic and lysogenic. In the lytic cycle, the phage binds to the bacterium and
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injects its DNA into the host cell. New phage particles are synthesized and assembled,
forming progeny that ultimately lyse the bacterium. In the lysogenic cycle, phage may
complete the lytic cycle or establish lysogeny, a latent infection, in the host bacterium. In
lysogeny, the phage genome typically circularizes and is either maintained as an
extrachromosomal plasmid (Dedrick, R., 2016) or the phage genome recombines with
the host genome, forming a lysogen. Phage that have the ability to form lysogens are
described as ‘temperate’ (Campbell, 2003) .
M. chelonae and M. marinum are pathogenic species of mycobacteria that are
closely related to M. tuberculosis (Ioachimescu, 2010). We decided to use these species
for this study because they are pathogenic, are relatively fast growers and are much safer
to work with than M. tuberculosis. M. chelonae was originally isolated from a sea turtle
and M. marinum was originally isolated from a carp (Manniko, 2011; Aronson, 1926).
Both M. chelonae and M. marinum cause tuberculosis in fish and can cause opportunistic
infections in humans (Spickler, A., 2006). Only the host range of 13 M. smegmatis phage
isolates have been previously tested on M. chelonae and M. marinum. Only 5 of these
phage infected M. chelonae: Bxb2 (A3), L5 (A2), PG2 (B1), Cooper (B4), and Wildcat
(V). However, none of the phage tested were able to infect M. marinum (Rybniker, J.,
2003). No previous experiments have determined the ability for M. smegmatis phage
isolates to form lysogens in either M. chelonae or M. marinum, though prophage have
been identified in both genomes (Stinear, T., 2008; Sewell, E., unpublished).
The goal of this project is to use phage isolated from the non-pathogenic host, M.
smegmatis, to study lysogenic relationships between phage and pathogenic hosts. To do
this, we determined which phage isolates could successfully infect M. chelonae and M.
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marinum. For phage that could successfully infect these species, the plating efficiencies
were determined. Phage that demonstrated high plating efficiencies were used for lysogen
isolation and characterization. Studying how phage establish and maintain lysogeny in
these alternative mycobacterial species leads to a better overall understanding of the
physiology of the host. This understanding is ultimately essential in developing future
detection methods and treatments for bacterial diseases like tuberculosis.

2.0 Literature review

2.1 Prophage in pathogens.
A prophage is the genetic material of a phage integrated into a host genome
during lysogeny. All serious bacterial pathogens carry functional prophage that encode
virulence factors which impact the pathogenicity or fitness of the host bacterium
(Brussow, 2004). For example, the major subunits of E. coli 0157 virulence factors,
Shiga toxins 1 and 2, are encoded by prophage (Shaikh, N, 2003). These toxins are
extremely potent. They bind to the cells lining the large intestine and ultimately cause
symptoms such as bloody diarrhea, fever, and nausea. If the infection is serious enough, it
can cause blood clots in the kidney which may result in acute kidney injury of failure.
Other infectious diseases associated with bacterial pathogens carrying prophage
include diptheria, botulism, salmonella, and tuberculosis (Brussow, 2004). In addition to
contributing virulence factors, like toxins, a prophage can also impact bacterial fitness by
broadening the host’s metabolic capabilities, helping to eliminate competing organisms,
regulating phase variation, or affect quorum sensing. Salmonella typhimurium, for
3

example, acquires the ability to produce nitrate at an increased efficiency, which results
in the host expending less energy on the production of energetically inferior electron
acceptors (Lopez, C., 2012). Clostridium difficile has a prophage, phiCDHM1, that
encodes three homologs of bacterial genes from the accessory gene regulator quorum
sensing system (Hargreaves, K., 2014). Though several studies have investigated various
functional prophage genes and how they impact host fitness, there are many prophage
that have unknown functions. One example of a pathogenic species that carries a
prophage with an undetermined function is M. tuberculosis. Though it is hypothesized
that these prophage somehow increase host virulence, little is understood about how they
impact bacterial gene expression and pathogenicity.
2.2 Mycobacteria.
Mycobacteria are acid-fast bacteria. Though classified as gram-positive, its membrane
doesn’t fully fit the gram-positive or gram-negative classification (Schaechter, M., 2013).
Rather than a traditional cell wall structure, mycobacteria have a thick layer of
peptidoglycan studded with sugars that anchor an even thicker layer of mycolic acid. It is
slow-growing and forms waxy, pale yellow colonies on agar plates (Brennan, P, 2003).
Mycobacteria are immobile and rod-shaped bacteria and have a high GC content (6171%, except for Mycobacterium leprae). Mycobacteria are divided into three categories:
Mycobacterium tuberculosis complex, Mycobacterium leprae, and non-tuberculosis
mycobacteria (NTM). (Pfyffer, G., 2015).
The M. tuberculosis complex is made up of 6 species: M. bovis, M. africanum, M.
canetti, M. microti, M. pinnipedii, and of course, M. tuberculosis. These species of
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mycobacteria are capable of causing tuberculosis, the growth of nodules in tissues, in
humans and animals (Frothingham, R., 1994).
Mycobacterium leprae is the causative agent of leprosy, a disease causing skin
lesions and nerve damage. Though there were nearly 5.2 million cases of leprosy reported
in 1985, with the use of multi-drug therapy, leprosy has been virtually eliminated as a
public health threat in all countries (World Health Organization, 2017).
The NTM category comprises over 170 species of mycobacteria that do not cause
tuberculosis or leprosy. The NTM species populate a diverse array of environments,
including water, soil, and dust (Falkinham, J., 2013). This category includes
pathogenic bacteria that can cause opportunistic infections in humans, such as M.
chelonae and M. marinum, as well as non-pathogenic bacteria, such as M. smegmatis and
M. fortuitum (Faria, S., 2015).
2.3 Mycobacterium tuberculosis.
M. tuberculosis is the causative agent of tuberculosis, a disease that affects the
lungs. Tuberculosis is a serious public health issue. It is responsible for approximately 2
million deaths each year and most seriously affects underdeveloped countries that lack
public health education, healthy living conditions, and adequate medical care (Smith, I,
2003). People who are immunocompromised are the most susceptible to tuberculosis. In
fact, people with HIV are 31 times more likely to become co-infected with tuberculosis,
and tuberculosis is the leading cause of death among people living with HIV (World
Health Organization, 2017). The reason why tuberculosis is so harmful to
immunocompromised individuals is because M. tuberculosis is able to persist in the
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phagosome of macrophages after entering the body via contaminated aerosol droplets.
Normally, the phagosome containing the pathogen undergoes lysosomal fusion which
kills the bacteria. M. tuberculosis, however, is able to establish a latent infection within
the phagosome by preventing phagosome-lysosomal fusion (Jamwal, SV, 2016). As a
result, non-infected macrophages and lymphocytes surround the infected area in the lungs
as a way to block off the infection from the rest of the body. This leads to the formation
of nodules and granulomas, both characteristic signs of tuberculosis (Schluger, 1998).
All species in the M. tuberculosis complex carry at least one prophage, phiRV1
and phiRV2. M. tuberculosis H37Rv, the best-characterized strain of M. tuberculosis,
carries both prophage. The prophage are each ~10 kb in length. PhiRV1 is about 1.8 Mbp
into the M. tuberculosis genome, whereas PhiRV1 is further downstream at about 3 Mbp
(Cole, ST, 1998).
2.4 Mycobacterium chelonae and Mycobacterium marinum.

Both M. chelonae and M. marinum are marine pathogens that cause tuberculosis
in fish and can cause opportunistic soft-tissue infections in humans (Spickler, 2006).
Because they are closely related to M. tuberculosis, they make excellent, safe models to
study infectious disease (Ramakrishnan, 2004). M. chelonae was originally isolated from
a sea turtle in 1903 (Manniko, N, 2011). M. marinum was originally isolated from a
diseased carp from a Philadelphia aquarium in 1926 (Aronson, JD, 1926.). M. marinum
carries 10 prophage, named PhiMmar01-10. Two of these are full-length prophages
(Stinear, T., 2008). An intact prophage was recently identified in M. chelonae Bergey,
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including an integrase, a repressor, a transmembrane protein, a terminase, and lysins A
and B (Sewell, E., unpublished).

2.5 Mycobacteriophage abundance and diversity.
Bacteriophage, viruses that infect bacteria, are extremely abundant and diverse.
There are approximately 1031 bacteriophage on the planet and an estimated 1023
bacteriophage infections happen every second (Hendrix, 2003). Mycobacteriophage
(phage) are viruses that infect bacteria specific to the genus Mycobacterium. Over the
past 10 years, thousands of undergraduate students across the United States and in South
Africa have isolated, characterized, and analyzed phage genomes as part of Howard
Hughes Medical Institute’s Science Education Alliance (Jordan, 2014). So far, over 8,300
phage have been isolated from mycobacteria, with over 99% of them having been
isolated with the host M. smegmatis, a fast-growing and non-pathogenic species
(phagesdb.org).
Phage are extremely diverse and their genomes are highly mosaic. This means
that each phage genome is made up of a unique set of modules, but these modules are
also shared with the population through horizontal exchange with shared hosts (Pope, W.,
2015). To better understand relationships between phage, phage are sorted into clusters
based on genome-sequence similarity (Hatfull, GF, 2010). There are currently 27
clusters, A–Z, along with six singletons, phage that do not share at least 50% genome
similarity with other phage. Some clusters are further subdivided into subclusters. For
example, cluster A has 18 subclusters, A1–A18 (phagesdb.org).
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In this study, we aimed to identify M. smegmatis phage isolates that could infect
pathogenic species of mycobacteria by performing host range tests using phage from
clusters A–X. Phage from two unusual clusters, G and V, are of interest due to their
broad host range.
Cluster G has 41 members, and compared to other clusters, cluster G phage have
been studied thoroughly and their biology is well-understood. The cluster G mechanism
of lysogeny and host range is well studied. One member of this cluster, BPs, was isolated
in 2006 in Pittsburgh, Pennsylvania (phagesdb.org). Like other temperate cluster G
phage, BPs can form lysogens in M. smegmatis. It has a well-characterized genome with
genes necessary for lysogenic establishment and maintenance, such as a repressor, a crolike protein, and an integrase (Villanueva, V. M., 2015). Cluster G phage are unique in
that their repressor is integration-dependent (Broussard, G., 2013). This means that the
attP site is actually located within the coding region of the repressor. When integration
occurs, the attP site splits the repressor gene as it recombines with the host attB
sequence. As this process occurs, the repressor gene is truncated at the 3´ end. Because
the 3´ end encodes a protein sequence that targets the repressor for degradation, the
truncated form becomes stable and active (Villanueva, V. M, 2015). BPs infects M.
tuberculosis at a very low efficiency, but mutant phage that have already passed through
a primary round of M. tuberculosis infection can re-infect at an equal efficiency to that of
M. smegmatis (Jacobs-Sera, D, 2012).
Cluster V phage are relatively understudied. The cluster V contains three highlyconserved viruses: Cosmos, Wildcat, and EniyanLRS. For this study, we used the latter
of the two isolates. Wildcat was isolated from a football field in Latrobe, Pennsylvania in
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2003. EniyanLRS was isolated near a hospital in New Delhi, India (phagesdb.org).
Wildcat does not form lysogens in M. smegmatis (Hatfull, G.F., 2012). No genes have
been identified in the Wildcat genome that are indicative of lysogenic capability. It has
no obvious integrase, candidate repressors, or partitioning systems that would aid in the
maintenance of Wildcat as a plasmid in host cells (Hatfull, GF, 2012). Wildcat does not
infect M. tuberculosis or M. aichense and the host range of Wildcat has not been tested
on any other species (Rybniker, J., 2006).
2.6 Host range of mycobacteriophage.
One factor that is limiting what we know about phage diversity is that nearly all
phage have been isolated using M. smegmatis. Using alternative hosts and understanding
host range can provide insights into the continuous evolutionary tug-of-war between
phage and bacterium and can provide a context for interpreting both phage and bacterial
genomes (Hatfull GF, 2012).
Both M. chelonae and M. marinum have been used in previous host range studies.
One study tested 14 phages on 17 different mycobacterial strains. Phage from the
following clusters were able to infect M. chelonae: A2, A3, B4, V, and E. coli phage
PMG2. No phage were able to infect M. marinum. This is most likely due to some
inhibitory mechanism that M. marinum possesses, providing resistance either by
preventing phage replication or preventing proper phage binding on the cell membrane
(Rybniker, 2003). Additional M. chelonae and M. marinum strains need to be tested to
confirm these phenotypes (Jacobs-Sera, 2012).
2.7 Life cycles of mycobacteriophage.
9

Bacteriophage typically undergo one of two life cycles, lytic or lysogenic, upon
infecting a host. The lytic vs. lysogenic switch is well understood in the temperate phage,
Lambda (Goodsell, D, 2008). The switch is dependent on two regulatory repressor
proteins, CI and Cro, competing for an operator region. Infection by Lambda is initiated
when the phage tail fibers bind to specific membrane receptors, lamB, on the bacterium.
The phage injects its DNA into the host cell, the DNA circularizes at cos sites, and early
genes are transcribed, which include CI, CII, CIII, and Cro. When nutrient availability
favors lysogeny, CIII prevents CII from being degraded by cellular proteases (Goodsell,
D, 2008). This results in the production of CI, which blocks genes essential for lytic
growth, and integrase. This is necessary for facilitating site-specific recombination at an
attachment site in the phage genome into a homologous site into the host genome, attP
and attB, respectively. Phage that can form lysogens are described as ‘temperate.’
When nutrient availability favors lytic growth, CIII is unable to prevent CII
degradation and CII cannot compete with Cro, which represses the expression of CI
(Trempy, 2003). Genes necessary for lysis of the host cell, such as Lysin A and Lysin B,
are expressed. Structural genes that encode tail and capsid proteins are also expressed in
order to make progeny, which are ultimately released upon host cell lysis (Trempy,
2003).

3.0 Materials and methods
3.1 Bacterial growth conditions.
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M. smegmatis mc 155 (ATCC: 700084; NC_008596.1) was used as a control for
2

host range testing of mycobacteriophage isolates. M. smegmatis was grown at 28.0° C
with shaking in complete 7H9 broth (Becton Dickinson (BD), Franklin Lakes, NJ),
supplemented with 10% albumin dextrose (AD) and 1 mM CaCl2, 50 µg mL-1
carbenecillin (Sigma, St. Louis, MO), and 10 µg mL-1 cycloheximide (Sigma). M.
chelonae Bergey (ATCC: 19535; NZ_CP010946.1) was used for host range testing of
mycobacteriophage isolates and for lysogen isolation. M. marinum F1, an isolate from
flounder and gift from William Kelleher (Kennebec River Biosciences), was used for
host range testing of mycobacteriophage isolates only. Cultures were grown at 28.0° C
with shaking in complete 7H9 broth supplemented with 10% oleic albumin dextrose
(OAD) and 1 mM CaCl2.
3.2 Viruses.
A total of 32 mycobacteriophage isolates representative of clusters A–X, were
used in the host range assays. All phage were isolated and cultured in the host M.
smegmatis unless otherwise specified (Table 1). Phage samples were stored in phage
buffer solution (10 mM Tris (pH 7.5), 10 mM MgSO4, 68 mM NaCl, and 1 mM CaCl2).
3.3 Host susceptibility testing.
Lysates of 32 phage were serially diluted in phage buffer and quantities of 5 ✕
106, 5 ✕ 104, 5 ✕ 102, and 5 particle forming units (PFUs) were applied to lawns of M.
smegmatis and M. chelonae plated with 4.5 ml of 7H9 top agar onto L-agar plates. The
plates were incubated at 30° C and examined at 48 h for plaques.
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3.4 Full-titer assays and plaque recovery of mycobacteriophage on M. chelonae.
Virus stocks (109 PFU ml-1) were serially diluted 10-fold and added to 0.5 mlaliquots of late-log phase bacterial cultures in 10-µl quantities. After 30 min, the cells
were plated in 4.5 ml of 7H9 top agar onto L-agar plates containing 50 µg mL
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carbenecillin and 10 µg mL-1 cyclohexamide. Plates were incubated at 30° C and checked
for plaque presence after 2 d. Efficiency of plating for each virus was determined by
dividing the titer of virus in M. chelonae by the titer in M. smegmatis. To determine if
passage through M. chelonae after the primary infection affected the plating efficiency,
plaques formed by BPs and Wildcat from the primary titer in M. chelonae were picked
into 100 µl of phage buffer. Titers were performed on virus samples as described
above. The plating efficiencies were calculated and were compared to the original
plating efficiency from the primary infection in M. chelonae.

3.5 Lysogen isolation in M. chelonae and M. smegmatis.
To explore whether BPs, Wildcat, and EniyanLRS could form lysogens in M.
chelonae and M. smegmatis, 100 µl of high-titer lysate was applied to 7H10 agar plates
(BD). Late-log phase M. chelonae or M. smegmatis was serially diluted in 7H9 broth.
Each dilution was plated in 4.5 ml of 7H9 top agar on 7H10 plates either seeded with 108
PFUs of virus or not seeded with virus. Plates were incubated at 30° C for 4 d and the
efficiency of lysogeny was calculated. For each phage, 6 colonies from the seeded virus
12

plate were picked with a sterile stick and streaked onto 7H10 agar plates and allowed to
incubate at 30° C for 1 wk. Lysogen growth from that 7H10 plate was subcultured onto
an additional 7H10 plate and allowed to incubate for 1 wk. Lysogen culture from the
second master plate was inoculated into 5 ml of 7H9 media supplemented with 10% oleic
albumin dextrose and 1 mM CaCl2. The 5 ml cultures were incubated for 1 wk at 28° C
with shaking.
3.6 Lysogen confirmation: checking for phage particles in culture supernatant.
To confirm the presence of viral particles in M. chelonae lysogens of phages BPs,
Wildcat, and EniyanLRS, lysogen cultures were centrifuged at 2,000 xg at 25° C for 5
min. The supernatant was serially diluted 100-fold and applied in 10-µl quantities to
lawns of M. smegmatis and M. chelonae. Plates were incubated at 30° C for 2 d and
checked for plaque presence. To determine the concentration of phage particles in the
supernatant of lysogen cultures, a titer was performed on Wildcat and BPs lysogen
supernatants, as described above.

3.7 Lysogen confirmation: immunity assays.
To verify homoimmunity of BPs, Wildcat, and EniyanLRS lysogens, 0.5-ml
aliquots of lysogen strains were plated with 4.5 ml of 7H9 top agar onto either L-agar
plates containing 50 µg mL-1 carbenecillin and 10 µg mL-1 cyclohexamide (M. smegmatis
lysogens) or 7H10 plates supplemented with 10% OAD (M. chelonae lysogens). Ten-fold
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dilutions of phage lysates were spotted onto the solidified lysogens strains, along with a
control plate of either wild type M. smegmatis or wild type M. chelonae. Plates were
incubated at 30° C and examined at 48 h for plaques.
3.8 DNA isolations of lysogens.
Cells were harvested from late-log lysogen cultures, resuspended in lysis buffer
(50 mM Tris-Cl, 5 mM EDTA, lysozyme 1 ng/ul), and incubated overnight at 37° C.
Each lysogen sample was treated with 50 ul of 10% SDS and 2.5 ul of Proteinase K (20
mg/ml) and mixed by inversion. Samples were incubated at 65° C for 10 min before
performing extractions in equal volumes of TE-saturated phenol and chloroform. After
centrifuging samples at max speed for 3 min the aqueous layers were recovered. DNA
was precipitated in 1.25 M ammonium acetate and 50% ethanol. Samples were vortexed
and incubated overnight at −20° C and centrifuged at 20,000 x g for 30 min at 4° C. The
pellet was washed with with 70% ice-cold ethanol and resuspended in 50 ul of TE (10
mM Tris, pH 8.0; 1 mM EDTA).
3.9 Polymerase Chain Reaction of Wildcat and EniyanLRS lysogens.
Primers were designed to amplify a cluster V-specific gene, gp125 of Wildcat
(Fig. 10). PCR was performed in 25-µl volumes containing 1 ng lysogen DNA, 0.5 µM of
each primer, and Promega PCR mastermix with Taq polymerase (Promega, Madison,
WI) according to the manufacturer's recommendations. Reactions were incubated for 2
min at 95 ° C followed by 40 cycles of 30 s at 95° C, 30 s at 58° C, and 1 min at 72° C
and a final cycle of 5 min at 72° C.
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3.10 Agarose gel electrophoresis.
PCR products were separated on a 1.5% SeaKem LE agarose gel in Tris-acetateEDTA buffer (40 mM Tris-acetate, 20 mM HOAc, 2 mM EDTA). Gels were stained with
ethidium bromide (0.5 µg ml ) and visualized using a UV transilluminator.
-1

4.0 Results

4.1 Optimal optical density of M. chelonae for plaque assays.
To visualize plaques on bacterial lawns, the lawns need to be confluent. In order
to determine the optimal density needed for confluent lawns, a growth curve was
generated for M. chelonae growth at 28 °C over a period of 8 d (Fig. 1). Each day, the
OD of a ten-fold dilution of culture in growth media was determined using a
600

spectrophotometer. The actual culture density was estimated by multiplying the direct
reading from the spectrophotometer by 10 and an aliquot of the culture was plated. The
doubling time of M. chelonae at 28 °C is 8.6 h. M. chelonae cells form confluent lawns at
an OD of 7.2–7.5.
600
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Figure 1. Growth curve of M. chelonae. Optical density (OD600) of liquid cultures of
M. chelonae grown at 28 °C with shaking over time. The green square indicates the
optical density that results in confluent lawns.
4.2 Host range of M. smegmatis phage isolates.
In order to determine the host range of phage isolates from M. smegmatis, phage
lysates representative of 24 different clusters were applied to lawns of M. chelonae
Bergey and M. marinum F1 in doses of 5 ✕ 106, 5 ✕ 104, 5 ✕ 102, and 5 PFUs. No
phage were able to infect M. marinum. However, phage from 10 different clusters were
able to infect M. chelonae.
Phage Ollie (A3), Peaches (A4), Gumball (D), Brujita (I1), Adephagia (K),
Corndog (O), Papyrus (R), Jeon (W), and Gaia (X) formed plaques on M. chelonae at the
highest dose, 5 ✕ 106 PFUs, only. Phage Mynx (K) formed plaques on M. chelonae at
both 5 ✕ 106 and 5 ✕ 104 PFUs. Two phage, BPs (G) and Wildcat (V), formed plaques
at doses of ≥ 103 PFUs (Table 1, Fig. 2).
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To compare the relative plating efficiencies of phage infecting M. chelonae to M.
smegmatis, full-plate titers were performed on select phage isolates. Phage Mynx (K),
Ballislife (unclustered), Gumball (D), and Adephagia (K) had plating efficiencies < 10-3
(Table 2). Phage BPs (G) and Wildcat (V) had high efficiencies of plating, 0.41 and 4.0
✕ 10-2, respectively (Table 2).
To determine how plating efficiencies change after the initial infection and
passage of phage through M. chelonae, particles were recovered from BPs and Wildcat
plaques on lawns of M. chelonae. Titers were performed on recovered plaques to
compare the plating efficiency after passage through M. chelonae to that of the original
plating efficiencies. The new efficiencies of plating for BPs and Wildcat were 0.74 and
0.62, respectively. Compared to the efficiencies from the primary round of infection, BPs
showed a 1.8-fold increase in plating efficiency and Wildcat showed a 15.5-fold increase
in plating efficiency (Table 2).
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Figure 2. Host range assays of mycobacteriophage representing clusters A–X. Phage
were applied to lawns of M. smegmatis (A. and C.) and M. chelonae (B. and D.) in doses
of 5 ✕ 10 , 5 ✕ 10 , 5 ✕ 10 , and 5 PFUs. Phage BPs and Wildcat infected M. chelonae
with high efficiencies of plating.
6

4

2
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When comparing the full-plate titrations of BPs and Wildcat on M. chelonae and
M. smegmatis, we noticed that the plaque morphologies in these species differed for both
phage. The plaque morphologies in M. chelonae were much more turbid than the plaques
formed on M. smegmatis (Fig. 3).

Figure 3. Plaque morphology of Wildcat and BPs on M. chelonae and M. smegmatis.
The plaque morphology of Wildcat (A and B) and BPs (C and D) differs significantly on
lawns of M. chelonae compared to M. smegmatis. Plaques recovered from lawns of M.
chelonae were re-plated onto lawns of M. chelonae and M. smegmatis. The plaques
formed on M. chelonae are more turbid. This morphology could be due to a lysogenic life
cycle or increased phage stability in the host.
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4.3 Wildcat and BPs form lysogens in M. chelonae.
To determine if phage BPs and Wildcat are capable of forming lysogens in M.
chelonae, dilutions of M. chelonae were plated onto plates seeded with virus. Virusresistant colonies were chosen and cultured with media allowing for lysogen growth. To
confirm if putative lysogen isolates released phage particles in their supernatant, lysogen
cultures were centrifuged and the supernatant was extracted. Plaque assays were
performed on lawns of both M. smegmatis and M. chelonae after two passages of the
lysogen from the original virus-seeded plate. The supernatants of all putative lysogens of
BPs and Wildcat formed plaques on both species (Fig. 4).
In order to quantify the release of viral particles from the lysogens, full-plate
titrations were performed on Wildcat and BPs lysogen supernatants. The titer of each
lysogen supernatant was measured. The average titer of BPs lysogens was 3.3 ✕ 105
(SE= 2.53 ✕ 105). The average titer of Wildcat lysogens was 6.45 ✕ 105 (SE= 1.33 ✕
105).
Superinfection immunity is observed as the inability of phage to form plaques on
a lysogen, while still maintaining the ability to form plaques on a wild type strain of
bacteria (Berngruber, T., 2010). Superinfection assays were performed on both BPs and
Wildcat lysogens in M. chelonae and the plaques formed on the lysogen strain plates
were compared to those formed on the wild type M. chelonae. Plaques were not present
on the BPs M. chelonae lysogen, but were visible on wild type M. chelonae to the 103
viral dose (Fig. 5). For the Wildcat M. chelonae lysogen, a plaque was visible on the 1010
viral dose. Plaques were visible on the wild type M. chelonae to the 103 viral dose (Fig.
6).
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To confirm that the Wildcat genome has integrated into the M. chelonae genome,
we performed agarose gel electrophoresis to detect PCR products from primers designed
to amplify a conserved cluster V gene, gp125 (Fig. 10). The 500-bp product was visible
in Wildcat lysate sample, which was our positive control. No bands were visible in any of
the putative Wildcat M. chelonae lysogen samples.

Figure 4. Detection of phage particles in culture supernatant of BPs (A) and Wildcat
(B) lysogens of M. chelonae on lawns of M. chelonae. BPs (A) and Wildcat (B) M.
chelonae lysogen supernatants were applied to a lawn of M. chelonae.
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Figure 5. Immunity assay of BPs M. chelonae lysogen compared to control. BPs
lysate in doses of 107, 105, 103, and 10 PFUs were applied to a lawn of BPs M. chelonae
lysogen (A) and to a lawn of wild type M. smegmatis (B).

Figure 6. Immunity assay of Wildcat M. chelonae lysogen compared to control. Tenfold dilutions of Wildcat lysate were applied to a lawn of Wildcat M. chelonae lysogen
(A) and to a lawn of wild type M. smegmatis as a positive control (B).
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4.4 EniyanLRS forms lysogens in M. smegmatis.
To determine if EniyanLRS, a second cluster V phage, could also form lysogens,
dilutions of M. smegmatis or M. chelonae were plated onto plates seeded with virus.
Virus-resistant colonies were chosen and cultured in liquid media for at least 3 passages
before performing lysogen confirmation tests. Lysogens were confirmed by detecting free
phage particles in culture supernatant. EniyanLRS particles were detected in supernatant
of M. smegmatis putative lysogen cultures, but not in that of M. chelonae lysogens.
To determine if EniyanLRS M. smegmatis lysogens are immune to infection by
cluster V phage, superinfection immunity assays were performed. On the M. smegmatis
control, EniyanLRS formed plaques at doses of 107, 105, and 103. In contrast, EniyanLRS
did not form plaques at any of the doses on lawns of EniyanLRS lysogens (Fig. 8).
To confirm that the EniyanLRS genome is present in the lysogen cells we
performed PCR with the cluster V-specific primers on lysogen DNA (Fig. 10). The
expected 500-bp product was produced from PCR performed on positive control,
EniyanLRS lysate and on both EniyanLRS M. smegmatis lysogen samples, indicating
that EniyanLRS genome is present in the M. smegmatis lysogen cells.
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Figure 7. Detection of phage particles in supernatant of EniyanLRS lysogens of M.
smegmatis. EniyanLRS M. smegmatis lysogen supernatants were applied to a lawn of M.
smegmatis.

Figure 8. Immunity assay of EniyanLRS M. smegmatis lysogen compared to control.
Hundredfold dilutions of EniyanLRS lysate were applied to a lawn of EniyanLRS M.
smegmatis lysogen (A) and to a lawn of wild type M. smegmatis as a positive control (B).
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Figure 9. Gene map of EniyanLRS compared to Wildcat. Phamerator was used to
generate gene maps of EniyanLRS (top) and Wildcat (bottom). The purple shading
between the genomes shows regions of nucleotide similarity.
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Figure 10. Agarose gel electrophoresis of cluster V-specific PCR in Wildcat and
EniyanLRS lysogens. PCR with primers specific to a cluster V conserved gene, gp125,
was performed on water (lane 2), Wildcat lysate (lane 3), EniyanLRS lysate (lane 4),
Wildcat M. chelonae lysogens (lanes 5, 6, and 7) and EniyanLRS M. smegmatis lysogens
(lanes 8 and 9). Lanes 1 and 10 contain molecular size markers.

5.0 Discussion

Despite increased public health efforts over the past century, bacterial pathogens
remain persistent causative agents for infectious diseases, such as salmonellosis,
botulism, and tuberculosis. All serious bacterial pathogens carry prophage, phage that
have integrated into the host chromosome during lysogeny (Brussow, 2004). The
functions of these prophage are widely understood in most pathogens, such as E. coli,
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however, they have yet to be determined in other pathogens. One example of such a
pathogen is M. tuberculosis, which carries two prophage, PhiRV1 and PhiRV2 (Cole, ST,
1998).
Mycobacteriophage are viruses that infect bacteria of the genus Mycobacterium.
Though there are more than 8,300 phage isolates, with most having been isolated in the
past decade, these isolates only begin to scratch the surface of phage diversity. One factor
that is limiting what we know about phage diversity is that nearly all phage have been
isolated using M. smegmatis. Using alternative hosts and understanding host range will
provide insights into the continuous evolutionary tug-of-war between phage and
bacterium and will provide a context for interpreting both phage and bacterial genomes
(Hatfull GF, 2015). Ultimately, understanding these relationships could provide
opportunities for better detection methods and treatments of bacterial diseases. In this
study, we have determined the host range of 32 phage isolates in M. chelonae and M.
marinum. In addition, we have identified phage that infected these alternative hosts the
most efficiently and determined the life cycles they use in these hosts. This work
provides a context for understanding lysogenic relationships between phage and their
hosts.

5.1 M. marinum and M. chelonae can be used to study relationships between phage
and pathogenic hosts.

In order to understand how phage impact the gene expression of pathogenic hosts,
we needed to identify pathogenic mycobacteria to work with that are safer than M.
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tuberculosis. We used alternative mycobacterial species M. chelonae and M. marinum for
phage isolation and host range assays. Though we have yet to successfully isolate phage
from these species, susceptibility tests provide us with interesting insights into the host
range of current phage isolates and also allow us to determine which phage isolates
should be used for lysogen isolation.
M. marinum is not susceptible to infection by any of the phage isolates we tested
(Table 1). This is consistent with previous studies in which the host range of 14 different
phage was tested on various mycobacterial species. Neither strain of M. marinum tested
was susceptible to any of the phage isolates from varying clusters (Rybniker, 2006). No
restriction systems have been identified in M. marinum, but phasmids based on phage T4
and L5 have been used to successfully transfect M. marinum, providing evidence for
either some inhibitory mechanism in M. marinum that prevents phage replication rather
than mycobacterial resistance to phage infection as a result of improper receptor binding
on the cell membrane (Rybniker, 2006).
5.2 The host range of 32 M. smegmatis phage isolates has been determined on M.
chelonae and M. marinum.

M. chelonae is susceptible to infection by phage isolates from the following
clusters: A3, A4, D, G, I1, K, O, R, V, W, and X (Table 1). However, all phage isolates
did not infect M. chelonae with the same efficiency. Phage Ollie (A3), Peaches (A4),
Gumball (D), Brujita (I1), Adephagia (K), Corndog (O), Papyrus (R), Jeon (W), and Gaia
(X) only formed plaques on lawns of M. chelonae at the highest dose, 5 ✕ 106 PFUs.
Phage Mynx (K) only formed plaques in doses of 5 ✕ 104 and 5 ✕ 106 PFUs. The
29

inability for these phage to efficiently infect M. chelonae could be due to restriction
modification systems that have been described in some strains of M. chelonae (Jones et
al., 1977). Resistance could also be attributed to superinfection immunity produced by a
prophage present in the host bacterial chromosome (Jacobs-Sera et al., 2012). Significant
remnants of an intact prophage have been identified in the M. chelonae Bergey strain,
however, it is unknown if the prophage encodes functional repressor proteins or toxinantitoxin systems that would suppress the infection of incoming phage (Sewell,
unpublished). The susceptibility patterns of M. chelonae differ compared to those of M.
tuberculosis, which as of now is limited to infection solely by phage from clusters A, B,
G, and K (Jacobs-Sera et al., 2012). This is interesting considering M. chelonae and M.
tuberculosis are both pathogenic and are closely related species.

Of the 32 phage tested on M. chelonae, phage BPs (G) and Wildcat (V) infected
the most efficiently. Both formed plaques on lawns of M. chelonae at the 5 PFUs lysate
dosage in addition to all higher doses. The problem with relying solely on spot testing to
investigate the susceptibility of M. chelonae is that it does not allow us to determine if the
plaque that is formed is due to legitimate infection or abortive infection, a resistance
mechanism used by the host that promotes cell death and limits viral replication (Fineran
et al. 2009). In addition, spot testing is not sufficient to quantify the efficiency of
infection. Unlike spot testing, full-plate titrations allow us to count individual PFUs and
calculate the plating efficiency, the ratio of the phage titer in M. chelonae compared to
that of M. smegmatis. The plating efficiencies of phage Adephagia, Mynx, Gumball, and
Ballislife were < 10-3. The plating efficiencies of BPs and Wildcat were 0.41 and
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4.0✕10-2, respectively (Table 2). Exceptionally high plating efficiencies suggest that
these viruses are somehow more ‘fit’ in expanding their host range to M. chelonae.
5.3 BPs and Wildcat mutants demonstrate an increased efficiency of plating.

After plaque recovery, phage BPs and Wildcat infected M. chelonae more
efficiently. Upon a second round of infection, BPs had a 1.8-fold increase in plating
efficiency while Wildcat had a 15.5-fold increase in plating efficiency (Table 2). Our
results are consistent with a previous study testing the host range of more than 220 phage
for M. tuberculosis and many different strains of M. smegmatis; this study showed that
after the initial passage of Halo and BPs through M. tuberculosis, the phage infected the
two bacterial species at equivalent efficiencies (Jacobs-Sera et al., 2012). It is likely that
passage through M. chelonae selected for phage with a mutation that allows more
efficient infection. For example, this could be due a single basepoint mutation in one of
the tail proteins of the phage, which could provide increased enzymatic activity for phage
penetration and injection. These tail fiber mutations have been documented in mutant
cluster G phage Halo and BPs after passage through M. tuberculosis (Jacobs-Sera et al.,
2012).
5.4 BPs is confirmed to form lysogens in M. chelonae.

A difference in plaque morphology is observed for both BPs and Wildcat in M.
chelonae compared to M. smegmatis (Fig. 3). The plaques generated by both phage in
full-plate titrations were clear in M. smegmatis, suggesting a lytic infection in which the
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virus uses the host’s transcriptional and translational machinery to create progeny and
ultimately lyses the bacterium. The plaques were more turbid in M. chelonae, suggesting
that the phage were undergoing the lysogenic life cycle in which the phage genome either
integrates itself with the bacterial chromosome or is maintained extrachromosomally and
remains in a ‘lysogen’ until unfavorable conditions arise. This phenotypic behavior was
expected in BPs, since it is able to form lysogens in its isolation host, M. smegmatis.
However, it was not expected in Wildcat, since it cannot form lysogens in M. smegmatis.
Putative lysogens of BPs and Wildcat in M. chelonae with efficiencies of
lysogeny of 26% and 24%, respectively. In addition to forming more turbid plaques on
M. chelonae, most BPs and Wildcat lysogen candidates release phage particles into their
supernatants (Fig. 4). Lysogens also demonstrate superinfection immunity, the prevention
of infection of an already-infected bacterial cell by similar phage (Berngruber, 2010). We
performed immunity assays on BPs lysogen cultures to demonstrate resistance to
superinfection. Plaques were not present on the BPs M. chelonae lysogen, but were
visible on wild type M. chelonae to the 103 viral dose (Fig. 5). Preliminary sequence
analysis confirms that BPs forms lysogens in M. chelonae and BPs is maintained by
integration into the host chromosome.
The ability for BPs to form lysogens in M. chelonae is not surprising since its
genome encodes an integrase (gp32), a type of recombinase that facilitates strand
exchange between the host genome and the phage genome, and a repressor (gp33), a
transcription factor that prevents the expression of lytic genes (Sampson et al., 2009). The
integration-dependent process by which BPs integrates into the M. chelonae genome is
well-understood. When integration occurs, the attP site splits the repressor gene as it
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recombines with the host attB sequence. As this process occurs, the repressor gene is
truncated at the 3' end. Because the 3' end encodes a protein sequence that targets the
repressor for degradation, the truncated form becomes stable and active (Broussard,
2013).
For the Wildcat M. chelonae lysogen immunity assay, a plaque was visible on the
1010 viral dose. Plaques were visible on the wild type M. chelonae to the 103 viral dose
(Fig. 6). To see if we could detect cluster V phage genomes in lysogen samples, we
performed agarose gel electrophoresis to detect PCR products designed to amplify
Wildcat gp125, which is conserved in cluster V phage. We could not detect the 500-bp
fragment in any of the putative Wildcat M. chelonae lysogens. If Wildcat gp125 is
disrupted during integration into the host genome, this could explain why we do not see
product. However, is more probable that there is some sort of contamination in the
Wildcat lysate since the samples still phenotypically behave like lysogens. Preliminary
sequence analysis demonstrated that the Wildcat M. chelonae lysogen sample was
contaminated with BPs particles.

5.5 Cluster V phage display different lysogen phenotypes in M. smegmatis.
To see if the Wildcat lysogen phenotype was consistent with cluster V phage, we
decided to repeat lysogeny experiments on an additional cluster V phage, EniyanLRS.
Putative lysogens of EniyanLRS in both M. chelonae and M. smegmatis were isolated.
EniyanLRS M. chelonae lysogens did not release phage particles into their culture
supernatants. Because of this, we concluded that EniyanLRS cannot form lysogens in M.
chelonae. However, surprisingly, EniyanLRS did form lysogens in M. smegmatis.
33

EniyanLRS M. smegmatis lysogen cultures release phage particles into their supernatants
(Fig. 7) and an immunity assay was also performed on EniyanLRS M. smegmatis
lysogens (Fig. 8). Plaques were not present on the EniyanLRS M. smegmatis lysogen, but
were visible on wild type M. smegmatis to the 103 viral dose. The cluster-V specific gene,
gp125, was detected by PCR in EniyanLRS M. smegmatis lysogen samples, indicating
the presence of the virus after multiple passages and lysogen stability. In addition,
preliminary sequence analysis of the EniyanLRS M. smegmatis lysogens shows that the
EniyanLRS genome is present in M. smegmatis. However, it is not integrated into the
host genome. Instead, it appears to be maintained in multiple copies extrachromosomally.
Interestingly, the EniyanLRS genome shows no obvious evidence of genes that
would aid in prophage stabilization. No repressor candidates have been identified in the
Wildcat genome, which is over 99% similar to the EniyanLRS genome (Hatfull, 2012).
Therefore, we will begin repressor searches at the few regions where EniyanLRS and
Wildcat are dissimilar. EniyanLRS also has no apparent ParAB system, which is found in
some phage that do not contain integrases, such as Redrock (A2). The ParAB system is a
method for extrachromosomal prophage maintenance (Dedrick, R., 2016). Further,
though EniyanLRS forms lysogens in M. smegmatis, Wildcat does not, despite the high
similarity of their genomes (Hatfull GF, 2012). EniyanLRS does encode for an Erf-like
recombinase, gp61, which is also found in P22, an enterobacteriophage isolated from
Salmonella typimurium, and is thought to promote genome circularization (Fenton et al.,
1984). EniyanLRS, however, does not have terminal repeats, and therefore, the encoded
Erf-like proteins likely perform alternative functions (Hatfull GF, 2012). This is the only
obvious recombinase that has been identified in the EniyanLRS genome, though an
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integrase-like DNA-binding domain has been identified on the N-terminus of EniyanLRS
gp121 (unpublished data).

5.6 Conclusions and future work.
This thesis contributes to the overall understanding of lysogenic relationships
between phage and pathogenic mycobacterial hosts. In order to determine how prophage
affect bacterial gene expression in M. chelonae or M. marinum, we first needed to
determine which M. smegmatis phage isolates could infect them. The host range of 32
phage isolates representative of clusters A–X was determined. Phage with high
efficiencies of plating were tested for their ability to form lysogens in these species. By
performing lysogen isolation procedures and confirmation experiments, we determined
that BPs can form lysogens in M. chelonae. When performing the same tests on cluster V
phage, we uncovered an interesting finding: despite the fact that the Wildcat and
EniyanLRS genomes are 99% similar, only EniyanLRS can form lysogens in M.
smegmatis.
Though some genes of interest have been identified in EniyanLRS that could play
a role in the phage’s ability to establish and maintain lysogeny, future bioinformatic
analysis needs to be performed to determine other gene candidates and putative gene
functions, focusing especially on potential genes that resemble a ParAB system since we
hypothesize that EniyanLRS is maintained extrachromosomally in M. smegmatis. Since
we already know that BPs has genes essential for establishing and maintaining lysogeny,
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future BPs M. chelonae lysogen sequence analysis will determine where BPs integrates
into the M. chelonae genome and if this location is the same as that of M. smegmatis.
Future work should also include additional host range testing on M. chelonae, M.
marinum, and other pathogenic models. In order to confirm legitimate infection and to
determine plating efficiencies, full-plate titrations need to be performed before and after
plaque recovery on all phage that initially formed plaques M. chelonae and on all phage
that form plaques on either M. chelonae or M. marinum in future experiments. This will
allow us to confirm the susceptibility of alternative pathogenic hosts to several phage
isolates representative of different clusters. It will also allow us to further compare their
susceptibility to that of more virulent mycobacterial species, such as M. tuberculosis.
Lastly, more phage should be tested on whether or not they can form lysogens in these
pathogenic hosts. Lysogens should be confirmed using lysogen culture supernatant tests,
superinfection immunity assays, PCR analysis, and DNA sequencing. To determine gene
expression of both the phage and the bacterium during a lysogenic state, RNAsequencing will ultimately be performed, allowing for comparative analysis at various
infection time points.
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